Matt Hancock reveals 80% drop in elderly Covid-19 hospital patients as he urges: ‘When the call comes - get the jab’

But Mr Hancock warned the public ‘don’t blow it now’ as the fall in infections slows
Michael Howie1 March 2021

Health Secretary Matt Hancock has revealed “exciting new data” showing the effectiveness of the Oxford and Pfizer Covid-19 vaccines.

Speaking at a Downing Street coronavirus briefing on Monday, Mr Hancock reported an 80 per cent drop in the number of over-70s being hospitalised with the disease.

He also formally invited people aged 60 and over to come forward for a jab.

Mr Hancock said the latest data proved the efficacy of both vaccines, urging: “When the call comes - get the jab.”

The health secretary said the number of new coronavirus cases is falling but the rate of decline has slowed, urging people to "keep sticking to the rules, let's not blow it now".

But the number of admissions to hospital was falling faster than that of cases - particularly among the older age groups who were vaccinated first.

"This is a sign that the vaccine is working," he said.

There was an even clearer sign in the data on deaths, Mr Hancock told the press conference, with the rate of decline in the older groups faster than in the under-80s.

"This shows, in the real world , across the UK right now that the vaccine is helping both to protect the NHS and to save lives."

"A single shot of either the Oxford/AstraZeneca vaccine or of the Pfizer vaccine works against severe infection among the over-70s with a more than 80 per cent reduction in hospitalisations", Mr Hancock said.

"In fact, the detailed data show that the protection that you get from catching Covid 35 days after a first jab is even slightly better for the Oxford jab than for Pfizer, albeit both results are clearly very strong".

The results "may also help to explain why the number of Covid admissions to intensive care units among people over 80 in the UK have dropped to single figures in the last couple of weeks".

England’s deputy chief medical officer Professor Jonathan Van-Tam added that the new data on the effectiveness of the Oxford/AstraZeneca jab has "vindicated" the UK’s decision to roll it out to older age groups.

Some countries have refused to administer the vaccine to the over-65s because of a lack of information on its effectiveness in the older population.

However, a new study from Public Health England (PHE) suggests a single dose of the Pfizer or Oxford vaccine offers dramatic protection against hospital admission and severe disease in older people.

He said: "We took a view that it almost certainly would work. The PHE data have clearly vindicated that approach today".

Professor Van Tam said he’s "not here to criticise other countries” but think “the data emerging from our programme will speak for itself2.

“Other countries will doubtless be very interested in it," he said.

The Health Secretary also defended the Government's border arrangements following the detection of the cases of the Manaus variant.

He said home quarantine measures were already in place and travel restrictions on Brazil had been imposed before the hotel policy was implemented.

Mr Hancock said: "All the evidence is that the five cases that we know about followed those quarantine rules and that, I hope, is very reassuring to people.

"There is no evidence that the sixth case did not follow those quarantine rules - we need to obviously get in contact with the person in question."

The test was taken on February 12 or 13 and "we haven't seen any further knock-on transmissions in the data".

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in